- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cancer & Blood Specialists of Louisville Adds New PET/CT Scanner to Improve Cancer Treatment
Patients to benefit from new technology that enables physicians to more accurately diagnose and locate cancers.
FORT MYERS, FLA., August 23, 2019 — Cancer & Blood Specialists of Louisville, a practice in the American Oncology Network, LLC (AON), is now offering patients a powerful new diagnostic imaging system known as positron emission tomography/computed tomography (PET/CT). This technology combines the power of hybrid imaging in one exam to enable physicians to more accurately detect and pinpoint disease—helping to improve patient outcomes.
PET/CT scans are noninvasive and painless and take about 30 minutes to perform. In addition to providing state-of-the-art imaging data, PET/CT scans offer added comfort and convenience by reducing the number of diagnostic sessions a patient must undergo.
“PET/CT scans allow for the most accurate detection of the location, size and shape of tumors and lesions," explained Jeff Esham, MBA, RT(R)(T), AON vice president of radiation oncology and radiology. "With this technology, our physicians are able to see changes within the cancer in ways that had never before been possible.”
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
October 24th 2024Amivantamab's role in non–small cell lung cancer (NSCLC) has been a highlight of the lung cancer space this year, with the 2 most recent approvals based on data from the MARIPOSA and MARIPOSA-2 trials.
Read More
